A Tale of Two Pharma Giants: Eli Lilly’s Study Setback Sends Stock Tumbling, Novo Nordisk Stages a Comeback

The rivalry at the forefront of the global fight against obesity took a sharp new turn…

Evaluating Microsoft’s MAI-DxO: AI Diagnostic Performance Versus Physicians in Complex Cases

Recent advancements in artificial intelligence (AI) have enabled the development of sophisticated tools for medical diagnosis.…

Stormy Waters for Viking Line: Finnish Subsidy Cuts May Spark Shipping Shift to Sweden

The Finnish government’s proposal to slash state support for shipping by the equivalent of 400 million…

The Nordic Business Journal Business News Brief

Business News brief reporting on Rheinmetall, G5 Entertainment and Danish Freight Giant Maersk Rheinmetall, Europe’s largest…

Lundin Mining Posts Higher Q2 Revenue, But Challenges Linger

Vancouver, August 6, 2025 – Lundin Mining delivered a respectable second quarter, with revenue climbing to…

Stockholm’s Ambulance Crisis: Staff Shortages, Political Gridlock, and a System on the Brink

Stockholm is facing a serious ambulance crisis. At times this summer, central parts of the city—home…

Novo Nordisk’s Collapse: A Corporate Crisis Shaking Denmark’s Economy

Novo Nordisk, once Europe’s most valuable company, is grappling with substantial financial setbacks, shedding nearly 900…

Norway’s Oil Fund Under Fire: National Debate Erupts Over Investments in Israeli Companies Tied to Gaza War

In a controversy shaking Norway’s political and financial spheres, the world’s largest sovereign wealth fund—a symbol…

Danish Confidence, American Counterfeits: Novo Nordisk Battles Wave of Knockoff Drugs in U.S. Courts

As more Danes continue to pour investments into Novo Nordisk, the Danish pharmaceutical powerhouse is ramping…

Denmark’s “Ozempic Miracle” Hits a Wall – How one company’s profit warning turned a Nordic success story into a macro-economic headache

COPENHAGEN – On paper, Denmark had been the envy of Europe: record trade surpluses, unemployment at…